TP53 and non-small cell lung carcinoma: Additionally, expression of p53 protein and its pro-apoptotic activity (in response to cisplatin treatment) in NSCLC was shown to be upregulated and enhanced after inhibition of miRNA-98-5p, thus proving this miRNA involvement in cisplatin resistance [73].